AJR 2005; 184:999-1003.
DeSouza NM, O'Neill R, McIndoe GA, Dina R, Soutter WP.
OBJECTIVE: We sought to describe MDCT and MRI features and tumor marker levels that differentiate borderline ovarian tumors from stage I ovarian tumors.
CONCLUSION: Borderline ovarian tumors are complex masses with imaging features similar to stage I tumors. The thickness of septations and the size of solid components are significantly larger in stage I tumors, and these features may be helpful for predicting likelihood of invasive tumors. However, neither feature allows confident differentiation of borderline tumors from stage I disease.